Treatment response monitoring in chronic phase CML (CP-CML) patients receiving tyrosine kinase inhibitor (TKI) therapy in US Oncology network. This is an ASCO Meeting Abstract from the 2013 ASCO ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results